Key facts
- It has raised $13.9M; the latest was Early Stage VC ($13.9M) in Jun 2025.
- Notable investors include HSG (Hong Kong), Founder Hesheng Investment, Hangzhou Capital, Essential Capital (China), Shuimu Wutong Investment — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for DarkJade Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for DarkJade Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DarkJade Sciences
Manufacturer of organoid smart devices and chips intended for the medical field. The company's core products cover organoid smart devices, organoid chips and kits, clinical testing and drug research and development services, organoid databases, and AI application software systems, providing clients with the ability to cultivate organoids on a larger scale and more efficiently.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2021
- Website
- darkjades.com/
- Ownership
- Privately Held (backing)
DarkJade Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DarkJade Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DarkJade Sciences in its N-PORT filings yet. We sweep new filings monthly.